Analysis of graft survival in a trial of stem cell transplant in ALS

OBJECTIVE: The first US Food and Drug Administration–approved clinical trial to treat amyotrophic lateral sclerosis (ALS) with neural stem cell–based therapy is in progress. The goal of the current study was to identify and assess the survival of human spinal cord–derived neural stem cells (HSSCs) t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadesse, Tezeta, Gearing, Marla, Senitzer, David, Saxe, Debra, Brat, Daniel J, Bray, Robert, Gebel, Howard, Hill, Charles, Boulis, Nicholas, Riley, Jonathan, Feldman, Eva, Johe, Karl, Hazel, Thomas, Polak, Meraida, Bordeau, Jane, Federici, Thais, Glass, Jonathan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265061/
https://www.ncbi.nlm.nih.gov/pubmed/25540804
http://dx.doi.org/10.1002/acn3.134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265061/
https://www.ncbi.nlm.nih.gov/pubmed/25540804
http://dx.doi.org/10.1002/acn3.134

Ejemplares similares